Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof
US-2024360072-A1 · Oct 31, 2024 · US
US9139554B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9139554-B2 |
| Application number | US-200913123307-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 9, 2009 |
| Priority date | Oct 9, 2008 |
| Publication date | Sep 22, 2015 |
| Grant date | Sep 22, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides superior compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of specific target proteins at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.
Opening claim text (preview).
The invention claimed is: 1. An amino lipid having the structure:
Related publications grouped by family.
Answers are generated from the same data shown on this page.